References
- Bishop J M. Molecular themes in oncogenesis. Cell 1991; 64: 235–48
- Knudson A G. Antioncogenes and human cancer. Proc Natl Acad. Sci. USA 1993; 90: 10914–21
- Bodrug S, Warner B J, Bath M L, Lindeman G J, Harris A W, Adams J M. Cyclin Dl transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124–30
- Wang T C, Cardiff R D, Zukerberg L, Lees E, Arnold A, Schmidt E V. Mammary hyperplasia and carcinoma in MMTV-cyclin Dl transgenic mice. Nature 1994; 369: 669–71
- Buckley M F, Sweeney K JE, Hamilton J A, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127–33
- Musgrove E A, Hamilton J A, Lee C SL, Sweeney K JE, Watts C KW, Sutherland R L. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 1993; 13: 3577–87
- Musgrove E A, Lee C SL, Buckley M F, Sutherland R L. Cyclin Dl induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 1994; 91: 8022–6
- Watts C KW, Sweeney K JE, Warlters A, Musgrove E A, Sutherland R L. Antiestrogen regulation of cell cycle progression and cyclin Dl gene expression in MCF7 human breast cancer cells. Breast Cancer Res Treat 1994; 31: 95–105
- Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573–82
- Sutherland R L, Reddel R R, Green M D. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. Eur J Cancer Clin Oncol 1983; 19: 307–18
- Musgrove E A, Sutherland R L. Steroids, growth factors and cell cycle controls in breast cancer. Regulatory mechanisms in breast cancer, M E Lippman, R B Dickson, M E Lippman, R B Dickson. Kluwer Academic Publishers, Boston 1991; 305–31
- Musgrove E A, Lee C SL, Sutherland R L. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 1991; 11: 5032–43
- Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335–44
- Taylor I W, Hodson P J, Green M D, Sutherland R L. Effects of tamoxifen on cell cycle progression synchronous MCF-7 human mammary carcinoma cells. Cancer Res 1983; 43: 4007–10
- Musgrove E A, Wakeling A E, Sutherland R L. Points of action of estrogen antagonist and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res 1989; 49: 2398–404
- Musgrove E A, Sutherland R L. Effects of the progestin antagonist RU 486 on T-47D cell cycle kinetics and cell cycle regulatory genes. Biochem Biophys Res Commun 1993; 195: 1184–90
- Baldin V, Lukas J, Marcote M J, Pagano M, Draetta G. Cyclin Dl is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812–21
- Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M, Bartek J. Cyclin Dl protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353–61
- Cocks B G, Viaro G, Bodrug S E, Hamilton J A. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem 1992; 267: 12307–10
- Matsushime H, Roussel M F, Ashmun R A, Sherr C J. Colonystimulating factor 1 regulates novel cyclins during the Gl phase of the cell cycle. Cell 1991; 65: 701–13
- Won K-A, Xiong Y, Beach D, Gilman M Z. Growth regulated expression of D-type cyclin genes in human diploid tibroblasts. Proc Natl Acad Sci USA 1992; 89: 9910–4
- Quelle D E, Ashmun R A, Shurtleff S A, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559–71
- Fantl V, Smith R, Brookes S, Dickson C, Peters G. Chromosome Ilql3 abnormalities in human breast cancer. Cancer Surveys 1993; 18: 77–93
- Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin Dl in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812–7
- Harris A L. p53 expression in human breast cancer. Adv Cancer Res 1992; 59: 69–88